Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PentaLyte: Began Phase I testing

BioTime Inc. (BTX), Berkeley, Calif.
Product: PentaLyte
Business:

Read the full 85 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE